Is Glycogen Storage Disease hereditary?

Glycogen Storage Disease (GSD) is a group of hereditary genetic disorders caused by mutations in genes that regulate the synthesis or breakdown of glycogen. Because these conditions are inherited through DNA passed from parents to children, they are strictly genetic and hereditary, typically following an autosomal recessive inheritance pattern.

Is Glycogen Storage Disease hereditary?

Yes, Glycogen Storage Disease is strictly hereditary, meaning the condition is caused by pathogenic variants (mutations) in an individual's DNA that are inherited from their biological parents. It is important to distinguish that while all hereditary conditions are genetic, not all genetic conditions are inherited (some are de novo). In the vast majority of Glycogen Storage Disease types, the condition is passed down from parents who are asymptomatic carriers of the mutation.

What is the inheritance pattern of Glycogen Storage Disease?

Most forms of Glycogen Storage Disease, such as GSD type I (von Gierke disease), follow an autosomal recessive inheritance pattern. This means an affected child must inherit one faulty gene copy from each parent. In this scenario, each parent is a "carrier" with one normal gene and one mutated gene, showing no symptoms themselves. Occasionally, specific types like GSD type IX can be X-linked, meaning the mutation is located on the X chromosome, which affects inheritance probabilities for males and females differently.

What are the risks for siblings and children of affected individuals?

When both parents are carriers of an autosomal recessive form of Glycogen Storage Disease, the statistical risks for each pregnancy are as follows:

• 25% chance the child will have the disease (inheriting two mutated copies).


• 50% chance the child will be an asymptomatic carrier (inheriting one mutated copy).


• 25% chance the child will be unaffected and not a carrier.

For individuals with Glycogen Storage Disease planning a family, the risk to their children depends on whether their partner is a carrier of a mutation in the same gene. Given the rarity of these conditions, the likelihood of a partner being a carrier is generally low, unless they are related or from a population with a higher carrier frequency.

How is genetic testing utilized for diagnosis and family planning?

Genetic testing is the gold standard for confirming a diagnosis of Glycogen Storage Disease. It involves sequencing specific genes to identify the exact mutation responsible for the metabolic disruption. Clinical geneticists recommend testing when clinical symptoms (such as hypoglycemia, hepatomegaly, or muscle weakness) suggest a metabolic disorder. For families, genetic counseling is essential to interpret these results, calculate recurrence risks, and discuss reproductive options, such as preimplantation genetic testing (PGT) or prenatal diagnostic testing like chorionic villus sampling (CVS).

Are de novo mutations common in Glycogen Storage Disease?

De novo (spontaneous) mutations, where a genetic change occurs for the first time in the affected individual and is not inherited from either parent, are extremely rare in Glycogen Storage Disease. Because these conditions are almost exclusively recessive, the presence of the disease almost always confirms that both parents are carriers of the mutation.

Next steps

• Consult with a clinical geneticist to confirm your specific subtype of Glycogen Storage Disease through molecular testing.


• Request a referral for genetic counseling if you are planning a pregnancy to understand your specific recurrence risks.


• Connect with the 379 members of the DiseaseMaps.org community to share experiences and find support from others navigating similar genetic journeys.


• Discuss with your metabolic specialist whether carrier testing for family members is appropriate.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Glycogen Storage Disease.


• Orphanet: Portal for rare diseases and orphan drugs.


• Online Mendelian Inheritance in Man (OMIM): Database of human genes and genetic disorders.


• Association for Glycogen Storage Disease (AGSD): Patient advocacy and support resources.